Elicio Therapeutics logo

Elicio Therapeutics Share Price (NASDAQ: ELTX)

$10.56

0.22

(2.13%)

Last updated on

Check the interactive Elicio Therapeutics Stock chart to analyse performance

Elicio Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$10.40
    Today's High:$10.56

    Day's Volatility :1.52%

  • 52 Weeks Low:$3.70
    52 Weeks High:$12.42

    52 Weeks Volatility :70.21%

Elicio Therapeutics Stock Returns

Period Elicio Therapeutics IncIndex (Russel 2000)
3 Months
35.61%
0.0%
6 Months
34.06%
0.0%
1 Year
171.58%
0.0%
3 Years
951.0%
-4.1%

Elicio Therapeutics Inc Key Stats

Check Elicio Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$10.34
Open
$10.4
Today's High
$10.56
Today's Low
$10.4
Market Capitalization
$168.9M
Today's Volume
$138.9K
52 Week High
$12.42
52 Week Low
$3.7
Revenue TTM
$0.0
EBITDA
$-44.4M
Earnings Per Share (EPS)
$-3.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-60013.19%

Stock Returns calculator for Elicio Therapeutics Stock including INR - Dollar returns

The Elicio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Elicio Therapeutics investment value today

Current value as on today

₹2,78,152

Returns

₹1,78,152

(+178.15%)

Returns from Elicio Therapeutics Stock

₹1,72,868 (+172.87%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Elicio Therapeutics Stock

189%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Elicio Therapeutics Stock from India on INDmoney has increased by 189% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Elicio Therapeutics Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Elicio Therapeutics(by analysts ranked 0 to 5 stars)

Elicio Therapeutics Share Price Target

What analysts predicted

Upside of 18.37%

Target:

$12.50

Current:

$10.56

Elicio Therapeutics share price target is $12.50, a slight Upside of 18.37% compared to current price of $10.56 as per analysts' prediction.

Elicio Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, ELTX stock has moved up by 930.4%

Elicio Therapeutics Technicals Summary

Sell

Neutral

Buy

Elicio Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Elicio Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
 Elicio Therapeutics Inc logo
7.14%
34.06%
171.58%
951.0%
-38.25%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Elicio Therapeutics Inc

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Organization
Elicio Therapeutics
Employees
32
CEO
Mr. Robert T. Connelly
Industry
Miscellaneous

Key Management of Elicio Therapeutics Inc

NameTitle
Mr. Robert T. Connelly
CEO, President & Director
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.
Founder & Independent Director
Dr. Peter DeMuth Ph.D.
Chief Scientific Officer
Dr. Christopher M. Haqq M.D., Ph.D.
Executive VP, Head of Research & Development and Chief Medical Officer
Dr. Darrell J. Irvine Ph.D.
Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Dr. Preetam Shah M.B.A., Ph.D.
Chief Strategy & Financial Officer and Treasurer
Ms. Megan C. Filoon
General Counsel, Secretary & Compliance Officer
Ms. Esther Welkowsky
Senior Vice President of Clinical Development
Ms. Joy Seymour
VP & Head of Regulatory Affairs
Dr. Thian Kheoh Ph.D.
Senior Vice President of Biometrics

Important FAQs about investing in ELTX Stock from India :

What is Elicio Therapeutics share price today?

Elicio Therapeutics share price today is $10.56 as on at the close of the market. Elicio Therapeutics share today touched a day high of $10.56 and a low of $10.40.

What is the 52 week high and 52 week low for Elicio Therapeutics share?

Elicio Therapeutics share touched a 52 week high of $12.42 and a 52 week low of $3.70. Elicio Therapeutics stock price today i.e. is closed at $10.56, lower by 14.98% versus the 52 week high.

How to invest in Elicio Therapeutics Stock (ELTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Elicio Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elicio Therapeutics Shares that will get you 0.1420 shares as per Elicio Therapeutics share price of $10.56 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Elicio Therapeutics Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics (ELTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Elicio Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Elicio Therapeutics share’s latest price of $10.56 as on August 30, 2025 at 1:29 am IST, you will get 0.9470 shares of Elicio Therapeutics. Learn more about fractional shares .

What are the returns that Elicio Therapeutics has given to Indian investors in the last 5 years?

Elicio Therapeutics stock has given -38.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?